tiprankstipranks
Trending News
More News >
Elite Pharmaceuticals (ELTP)
OTHER OTC:ELTP
US Market
Advertisement

Elite Pharmaceuticals (ELTP) Ratios

Compare
367 Followers

Elite Pharmaceuticals Ratios

ELTP's free cash flow for Q2 2026 was $0.39. For the 2026 fiscal year, ELTP's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
8.04 3.07 2.75 2.82 2.10
Quick Ratio
6.34 2.08 1.53 1.81 1.24
Cash Ratio
2.49 0.54 1.00 1.28 0.55
Solvency Ratio
0.35 0.83 369.58 1.04 0.66
Operating Cash Flow Ratio
2.13 -0.25 0.43 0.97 0.55
Short-Term Operating Cash Flow Coverage
23.66 -0.76 10.74 18.39 7.77
Net Current Asset Value
$ 40.80M$ 13.94M$ 9.57M$ 8.93M$ 2.16M
Leverage Ratios
Debt-to-Assets Ratio
0.03 0.14 0.10 0.08 0.09
Debt-to-Equity Ratio
0.05 0.20 0.13 0.11 0.15
Debt-to-Capital Ratio
0.05 0.17 0.12 0.10 0.13
Long-Term Debt-to-Capital Ratio
0.04 0.05 0.11 0.05 0.10
Financial Leverage Ratio
1.90 1.45 1.41 1.39 1.62
Debt Service Coverage Ratio
12.41 4.55 302.38 14.67 10.25
Interest Coverage Ratio
122.96 18.33 1.82K 26.44 8.11
Debt to Market Cap
<0.01 0.05 0.13 0.05 0.04
Interest Debt Per Share
<0.01 0.01 <0.01 <0.01 <0.01
Net Debt to EBITDA
-1.06 1.79 -0.61 -0.92 -0.14
Profitability Margins
Gross Profit Margin
52.66%46.55%48.58%45.86%46.76%
EBIT Margin
6.90%1.86%0.01%15.72%8.29%
EBITDA Margin
17.92%4.56%0.02%19.42%23.36%
Operating Profit Margin
34.31%19.05%5.93%15.72%8.29%
Pretax Profit Margin
19.32%0.82%11.67%19.54%16.33%
Net Profit Margin
11.33%35.51%12.91%27.58%20.05%
Continuous Operations Profit Margin
0.18%35.51%0.01%27.58%20.05%
Net Income Per EBT
58.64%4342.25%110.64%141.14%122.77%
EBT Per EBIT
56.32%4.29%196.82%124.33%196.93%
Return on Assets (ROA)
11.88%24.04%10783.21%25.32%19.43%
Return on Equity (ROE)
27.95%34.92%15227.43%35.28%31.50%
Return on Capital Employed (ROCE)
39.56%15.28%6125.12%17.82%10.33%
Return on Invested Capital (ROIC)
29.56%619.48%6710.61%22.29%12.32%
Return on Tangible Assets
12.48%26.01%12762.06%31.21%26.02%
Earnings Yield
2.23%12.94%15012.72%25.19%8.99%
Efficiency Ratios
Receivables Turnover
3.01 2.91 11.04K 10.55 7.26
Payables Turnover
16.99 11.15 7.18K 12.21 14.54
Inventory Turnover
3.20 2.34 1.84K 2.59 2.70
Fixed Asset Turnover
9.17 3.88 3.27K 4.62 3.70
Asset Turnover
1.05 0.68 835.17 0.92 0.97
Working Capital Turnover Ratio
1.73 2.79 2.64K 3.48 6.35
Cash Conversion Cycle
213.87 248.59 0.18 145.56 160.57
Days of Sales Outstanding
121.39 125.39 0.03 34.60 50.28
Days of Inventory Outstanding
113.96 155.93 0.20 140.87 135.40
Days of Payables Outstanding
21.48 32.73 0.05 29.90 25.11
Operating Cycle
235.35 281.32 0.23 175.47 185.68
Cash Flow Ratios
Operating Cash Flow Per Share
0.02 >-0.01 <0.01 <0.01 <0.01
Free Cash Flow Per Share
0.02 >-0.01 >-0.01 <0.01 <0.01
CapEx Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
0.95 1.25 -0.72 0.92 0.90
Dividend Paid and CapEx Coverage Ratio
21.14 -4.05 0.58 13.05 9.68
Capital Expenditure Coverage Ratio
21.14 -4.05 0.58 13.05 9.68
Operating Cash Flow Coverage Ratio
6.86 -0.28 0.86 2.34 1.34
Operating Cash Flow to Sales Ratio
0.18 -0.06 <0.01 0.20 0.13
Free Cash Flow Yield
3.48%-2.63%-8.16%17.01%5.06%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
44.76 7.73 <0.01 3.97 11.12
Price-to-Sales (P/S) Ratio
5.07 2.74 <0.01 1.09 2.23
Price-to-Book (P/B) Ratio
10.12 2.70 1.01 1.40 3.50
Price-to-Free Cash Flow (P/FCF) Ratio
28.75 -37.97 -12.25 5.88 19.76
Price-to-Operating Cash Flow Ratio
27.41 -47.34 8.80 5.43 17.72
Price-to-Earnings Growth (PEG) Ratio
0.22 -0.08 <0.01 0.06 -0.04
Price-to-Fair Value
10.12 2.70 1.01 1.40 3.50
Enterprise Value Multiple
27.21 61.95 3.96 4.72 9.41
Enterprise Value
599.36M 159.99M 25.43M 29.57M 55.77M
EV to EBITDA
27.21 61.95 3.96 4.72 9.41
EV to Sales
4.88 2.83 <0.01 0.92 2.20
EV to Free Cash Flow
27.67 -39.11 -10.60 4.92 19.47
EV to Operating Cash Flow
26.36 -48.76 7.62 4.54 17.46
Tangible Book Value Per Share
0.06 0.05 0.02 0.02 0.01
Shareholders’ Equity Per Share
0.06 0.06 0.03 0.02 0.02
Tax and Other Ratios
Effective Tax Rate
0.25 -42.42 -0.11 -0.28 -0.23
Revenue Per Share
0.11 0.06 33.72 0.03 0.03
Net Income Per Share
0.01 0.02 4.35 <0.01 <0.01
Tax Burden
0.59 43.42 1.11 1.41 1.23
Interest Burden
2.80 0.44 781.76 1.24 1.97
Research & Development to Revenue
0.06 0.12 0.18 0.13 0.20
SG&A to Revenue
0.10 0.12 0.15 0.14 0.13
Stock-Based Compensation to Revenue
<0.01 0.15 <0.01 0.02 0.04
Income Quality
1.63 -0.16 0.94 0.73 0.63
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis